| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/24/2002 | EP1223978A2 Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses |
| 07/24/2002 | EP1223976A1 Novel process for making human papillomavirus virus-like particles with improved properties |
| 07/24/2002 | EP1223973A2 Method of expressing antigens on the surface of antigen presenting cells by photochemical internalization |
| 07/24/2002 | EP1223966A2 Use of gdnf for treating corneal defects |
| 07/24/2002 | EP1223962A1 Method and compositions for inhibiting adhesion formation |
| 07/24/2002 | EP1223950A2 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
| 07/24/2002 | EP1223949A1 Extended release formulations of erythromycin derivatives |
| 07/24/2002 | EP1223947A1 Targeted vectors |
| 07/24/2002 | EP1223945A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 07/24/2002 | EP1223936A1 Oral formulations for anti-tumor compounds |
| 07/24/2002 | EP1223920A1 Edible mcc/pga coating composition |
| 07/24/2002 | EP1223918A1 Pharmaceutical compositions comprising a hmg coa reductase inhibitor |
| 07/24/2002 | EP1223916A2 Neutral-cationic lipid for nucleic acid and drug delivery |
| 07/24/2002 | EP1223915A1 Dry powder compositions having improved dispersivity |
| 07/24/2002 | EP1223914A2 Orally distintegrating composition comprising mirtazapine |
| 07/24/2002 | EP1146896B1 Monodisperse hexameric acylated insulin analog formulations |
| 07/24/2002 | EP1035841B1 Method for producing solid dosing forms |
| 07/24/2002 | EP0874632B1 High-content famciclovir tablets |
| 07/24/2002 | EP0861270B1 Photocured hyaluronic acid gel and method of preparation thereof |
| 07/24/2002 | EP0855907B1 Composition for transdermal delivery |
| 07/24/2002 | EP0821593B1 Conjugate of an active agent, a polyether and possibly a native protein regarded as acceptable by the body |
| 07/24/2002 | EP0799030B1 Powder formulations containing melezitose as a diluent |
| 07/24/2002 | EP0744942B1 Controlled release hydrogel formulation |
| 07/24/2002 | EP0742011B1 Percutaneously absorbable preparation |
| 07/24/2002 | EP0739210B1 Compositions for local delivery of cytostatic agents |
| 07/24/2002 | CN1360612A Film coatings and film coating compositions based on polyvinyl alcohol |
| 07/24/2002 | CN1360611A Neutral lipopolymer and liposomal compositions contg. same |
| 07/24/2002 | CN1360585A Method for preparing gama-unsaturated beta-lactone and use thereof as aromatic and flavouring ingredient |
| 07/24/2002 | CN1360507A Conjugates and method for production thereof, and their use for transporting molecules via biological membranes |
| 07/24/2002 | CN1360506A Growth hormone formulations |
| 07/24/2002 | CN1360505A Pseudomycin antifungal compositions and method for their use |
| 07/24/2002 | CN1360504A Taste masked pharmaceutical liquid formulations |
| 07/24/2002 | CN1360499A Pharmaceutical composition contg. fenofibrate and preparation method |
| 07/24/2002 | CN1360497A Controlled-release biocompatible ocular drug delivery implant devices and methods |
| 07/24/2002 | CN1360496A Dry powder compositions |
| 07/24/2002 | CN1360495A Intravaginal clindamycin ovule composition |
| 07/24/2002 | CN1360494A Delivery system for oral care compositions comprising organosiloxane resins using removable backing strip |
| 07/24/2002 | CN1360493A Compositions comprising organosiloxane resins for delivering oral care substances |
| 07/24/2002 | CN1360492A Compositions comprising organosiloxane resins for delivering oral care substances |
| 07/24/2002 | CN1360491A Preservatives for perishable preparations, in particular for cosmetic and pharmaceutical preparations |
| 07/24/2002 | CN1360467A Antimicrobial sanitizing lotion with skin protection properties |
| 07/24/2002 | CN1359677A Preparation of propofol with enhanced bacteria inhibition |
| 07/24/2002 | CN1088075C Polymer film composition for capsules |
| 07/24/2002 | CN1087951C Hypolipemic medicine for lossing weight and its preparing process |
| 07/24/2002 | CN1087943C Stable extract of hyperricum perforatum, process for preparing same and pharmaceutical compositions |
| 07/24/2002 | CN1087938C 东莨菪碱膏药 Scopolamine plaster |
| 07/24/2002 | CN1087933C Encapsulated medicine |
| 07/24/2002 | CN1087932C Proliposome powder for inhalation |
| 07/23/2002 | US6423750 Systems for delivering anti-infective compositions to treat disordered tissue such as cold sores |
| 07/23/2002 | US6423749 Pharmaceutical composition for injection based on paracetamol |
| 07/23/2002 | US6423720 Pyrimidine compounds and methods for making and using the same |
| 07/23/2002 | US6423687 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 07/23/2002 | US6423685 Method for increasing the serum half-life of a biologically active molecule |
| 07/23/2002 | US6423513 Polynucleotide encoding proprotein comprising cell recognition domain binding to exterior surface of targeted cell, domain effecting translocation to cell cytosol upon proteolytic cleavage, cytotoxicity domain, endoplasmic reticulum retention |
| 07/23/2002 | US6423351 Inhibiting oxidative degradation of pharmaceutical formulations |
| 07/23/2002 | US6423346 Fish gelatinous composition for use as an ingredient in tablets |
| 07/23/2002 | US6423345 Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
| 07/23/2002 | US6423341 A beta -lactam antibiotic-containing tablet which comprises a beta-lactam antibiotic such as cefixime or cefdinir, a low-substituted hydroxypropylcellulose and/or crosslinked polyvinylpyrrolidone as disintegrator and a binder |
| 07/23/2002 | US6423340 Gastrointestinal disorders, crohn's colitis |
| 07/23/2002 | US6423338 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 07/23/2002 | US6423334 Composition and method for enhancing transport across gastrointestinal tract cell layers |
| 07/23/2002 | US6423307 For use in the topical treatment of mucosal affections |
| 07/23/2002 | CA2215317C Reduction of adhesions using controlled delivery of active oxygen inhibitors |
| 07/23/2002 | CA2101556C Growth factor containing matrix for the treatment of cartilage lesions |
| 07/23/2002 | CA2097827C Enhanced bioavailability pharmaceutical composition containing probucol |
| 07/23/2002 | CA2059060C Cell surface receptor complimentation |
| 07/23/2002 | CA2042503C Novel bifunctional linking compounds, conjugates and methods for their production |
| 07/18/2002 | WO2002055736A2 Antisense imaging of gene expression of the brain in vivo |
| 07/18/2002 | WO2002055721A2 Modular transfection systems based on nucleoprotein filaments |
| 07/18/2002 | WO2002055720A2 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 07/18/2002 | WO2002055705A2 Proteins and nucleic acids encoding same |
| 07/18/2002 | WO2002055693A2 Method for inhibiting the expression of a target gene |
| 07/18/2002 | WO2002055544A2 Fibrin binding polypeptides useful inter alia in medical imaging processes |
| 07/18/2002 | WO2002055532A2 Variant growth hormone molecules conjugated with macromolecular compounds |
| 07/18/2002 | WO2002055530A2 Transcobalamin binding conjugates useful for treating abnormal cellular proliferation |
| 07/18/2002 | WO2002055108A1 Targeted modification of intracellular compounds |
| 07/18/2002 | WO2002055107A1 Topical anesthesia compositions |
| 07/18/2002 | WO2002055106A2 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| 07/18/2002 | WO2002055101A2 Storage stable powder compositions of interleukin-4 receptor |
| 07/18/2002 | WO2002055100A2 Method and composition for inhibition of tumor growth and enhancing an immune response |
| 07/18/2002 | WO2002055097A2 Conjugates of nucleosides with lactosaminated human albumine |
| 07/18/2002 | WO2002055089A2 Immunoassay technique using multispecific molecules |
| 07/18/2002 | WO2002055076A1 Cyclodextrin-containing pharmaceutical preparation |
| 07/18/2002 | WO2002055067A2 Fumaric acid derivatives as nf-kappab inhibitors |
| 07/18/2002 | WO2002055066A1 Fumaric acid derivatives as nf-kappa-b inhibitors |
| 07/18/2002 | WO2002055061A2 Method of producing porous tablets with improved dissolution properties |
| 07/18/2002 | WO2002055059A2 Method for preparing submicron particle suspensions |
| 07/18/2002 | WO2002055023A2 Therapeutic film forming composition and treatment system |
| 07/18/2002 | WO2002055021A2 Glycopolymers and free radical polymerization methods |
| 07/18/2002 | WO2002055020A2 Topical testosterone formulations and associated methods |
| 07/18/2002 | WO2002055011A2 Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof |
| 07/18/2002 | WO2002055009A1 Spaced drug delivery system |
| 07/18/2002 | WO2002054997A1 Devices for local and systemic delivery of active substances and methods of manufacturing thereof |
| 07/18/2002 | WO2002054868A2 Pulmonary delivery of polyene antifungal agents |
| 07/18/2002 | WO2002031025A3 Biodegradable poly(beta-amino esters) and uses thereof |
| 07/18/2002 | WO2002022109A3 Patch comprising diclofenac |
| 07/18/2002 | WO2002015937A3 Pharmaceutical composition for the systematic administration of pharmacologically active ingredients containing polyol fatty acid esters |
| 07/18/2002 | WO2002013856A3 W/o emulsion adjuvant compositions for vaccines |
| 07/18/2002 | WO2001089678A3 Emulsifiers |
| 07/18/2002 | WO2001087322A3 Peptide pharmaceutical formulations |